Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04745234
Recruitment Status : Recruiting
First Posted : February 9, 2021
Last Update Posted : August 17, 2021
Information provided by (Responsible Party):
Kyowa Kirin, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2024
Estimated Study Completion Date : March 2024